Search Result "cymserine"
Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 3 Year: 2014 Page: 452-459
Author(s): Sibhghatulla Shaikh,Syed S. Ahmad,Mohammad A. Ansari,Shazi Shakil,Syed M.D. Rizvi,Shahnawaz Shakil,Shams Tabrez,Salman Akhtar,Mohammad A. Kamal
Exploring N1-p-Fluorobenzyl-Cymserine as an Inhibitor of 5-Lipoxygenase as a Candidate for Type 2 Diabetes and Neurodegenerative Disorder Treatment
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 2 Year: 2014 Page: 197-202
Author(s): Qurrat ul Ain,Nigel H. Greig,Muhammad S. Nawaz,Sajid Rashid,Mohammad A. Kamal
Molecular Interaction Study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 Kinase and JNK Kinase
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2013 Page: 129-135
Author(s): Sidra Batool, Muhammad Sulaman Nawaz, Nigel H. Greig, Mohd Rehan, Mohammad A. Kamal
In Silico Ligand-Receptor Docking of Potentially Selective Butyrylcholinesterase Inhibitors Structurally Related to the Marine Natural Product Debromoflustramine B
Journal: Medicinal Chemistry
Volume: 6 Issue: 3 Year: 2010 Page: 141-143
Author(s): Miguel O. Mitchell, Robert W. Figliozzi, Mustafa Guzel
Multiple Targets for the Management of Alzheimerâs Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15 Issue: 10 Year: 2016 Page: 1279-1289
Author(s): Syed Sayeed Ahmad,Salman Akhtar,Qazi Mohammad Sajid Jamal,Syed Mohd. Danish Rizvi,Mohammad A. Kamal,M. Kalim A. Khan,Mohd. Haris Siddiqui
Specific Cholinesterase Inhibitors: A Potential Tool to Assist in Management of Alzheimer Disease
Ebook: Drug Design and Discovery in Alzheimer's Disease
Volume: 1 Year: 2015
Author(s): Nigel H. Grieg,Mohammad A. Kamal,Nasimudeen R. Jabir,Shams Tabrez,Faizul H. Nasim,Adel M. Abuzenadah,Gjumrakch Aliev
Doi: 10.1016/B978-0-12-803959-5.50006-4
Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 7 Year: 2017 Page: 820-827
Author(s): Mohammad A. Kamal,Shazi Shakil,Muhammad S. Nawaz,Qian-sheng Yu,David Tweedie,Y. Tan,Xianqin Qu,Nigel H. Greig
Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-β Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimers Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway
Journal: Current Alzheimer Research
Volume: 11 Issue: 6 Year: 2014 Page: 608-622
Author(s):
Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 3 Year: 2014 Page: 391-401
Author(s): Sibhghatulla Shaikh,Anupriya Verma,Saimeen Siddiqui,Syed S. Ahmad,Syed M.D. Rizvi,Shazi Shakil,Deboshree Biswas,Divya Singh,Mohmmad H. Siddiqui,Shahnawaz Shakil,Shams Tabrez,Mohammad A. Kamal
Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 8 Year: 2014 Page: 1432-1439
Author(s): Gohar Mushtaq,Nigel H. Greig,Jalaluddin A. Khan,Mohammad A. Kamal